Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesSerum 25(OH)D Levels Modulate the Acute Phase Response Associated to the First Nitrogen Containing Bisphosphonate Infusion
Journal of Bone and Mineral Research, 10/01/09
Bertoldo F et al. – The association between post–N–BPs APR and 25(OH)D suggests an interesting interplay among N–BPs, 25(OH)D and immune system but cannot prove a causal role of 25(OH)D in APR that has to be proven by RCT. However, if confirmed, it should have some practical implications in preventing APR.
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Article Search
Sponsor